PFBT
AUTL

Parkside Financial Bank & Trust’s Autolus Therapeutics AUTL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$1.29K – 2035
2023
Q4 		$1.29K Buy
+200
New +$763 ﹤0.01% 1569

Other funds holding AUTL

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parkside Financial Bank & Trust's AUTL Position: Q1 2024 in Review

Parkside Financial Bank & Trust sold out of Autolus Therapeutics (AUTL) in Q1 2024, closing a stake of 200 shares — an estimated $1.29K sold.

Parkside Financial Bank & Trust first reported a position in AUTL in Q4 2023 and held it in 1 quarter. The position peaked at $1.29K in Q4 2023. 121 funds tracked by Wall St. Rank hold AUTL as of Q1 2024.

  • Parkside Financial Bank & Trust reported no remaining Autolus Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 200 Autolus Therapeutics shares in Q1 2024, an estimated $1.29K.
  • Parkside Financial Bank & Trust first reported a position in Autolus Therapeutics in Q4 2023 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Autolus Therapeutics position peaked at $1.29K in Q4 2023.
  • 121 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2024, filed 1 May 2024.